Literature DB >> 33279505

The cardiac methylome: A hidden layer of RNA modifications to regulate gene expression.

K Shanmugha Rajan1, Subbiah Ramasamy2, Venkata Naga Srikanth Garikipati3, Vemparthan Suvekbala4.   

Abstract

Post-transcriptional RNA modification has been observed in all kingdoms of life and more than a hundred different types of RNA modifications decorate the chemical and topological properties of these ribose nucleotides. These RNA modifications can potentially alter the RNA structure and also affect the binding affinity of proteins, thus regulating the mRNA stability as well as translation. Emerging evidence suggest that these modifications are not static, but are dynamic; vary upon different cues and are cell-type or tissue-specific. The cardiac transcriptome is not exceptional to such RNA modifications and is enriched with the abundant base methylation such as N6-methyladenosine (m6A) and also 2'-O-Methylation (Nm). In this review we will focus on the technologies available to map these modifications and as well as the contribution of these post-transcriptional modifications during various pathological conditions of the heart.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Year:  2020        PMID: 33279505     DOI: 10.1016/j.yjmcc.2020.11.011

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  2 in total

1.  The lncRNA MIAT regulates CPT-1a mediated cardiac hypertrophy through m6A RNA methylation reading protein Ythdf2.

Authors:  Yiqing Yang; Muisha B Mbikyo; Junzhe Zhang; Yuan Zhang; Naijin Zhang; Zhao Li
Journal:  Cell Death Discov       Date:  2022-04-05

Review 2.  The plant epitranscriptome: revisiting pseudouridine and 2'-O-methyl RNA modifications.

Authors:  Muthusamy Ramakrishnan; K Shanmugha Rajan; Sileesh Mullasseri; Sarin Palakkal; Krishnan Kalpana; Anket Sharma; Mingbing Zhou; Kunnummal Kurungara Vinod; Subbiah Ramasamy; Qiang Wei
Journal:  Plant Biotechnol J       Date:  2022-05-11       Impact factor: 13.263

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.